CVS Caremark Corp. scored a resounding victory against a whistle-blower’s False Claims Act lawsuit concerning CVS’s pharmacy benefit management business with Medicare Part D plan sponsors, when a federal district court in Pennsylvania granted CVS summary judgment on all claims (United States ex rel. Spay v. CVS Caremark Corp., 2015 BL 306342, E.D. Pa., 2:09-cv-04672-RB, 9/22/15).
The lawsuit was filed by Anthony R. Spay, who owns a pharmacy audit company that performed an audit of some of CVS’s PBM claims and alleged that the company didn’t comply with Medicare regulations regarding drug utilization reviews. Spay’s allegations concerned ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.